Skip links
Get a free Consultation
Renova Aesthetic Institute
Meet the doctor
Board Certified in Family Medicine

Board-Certified Family Medicine Physician  ·  Miami

Dr. Humberto Fernandez Miro

Dr. Humberto Fernandez Miro is a highly esteemed board-certified physician with over 25 years of extensive experience in Miami's medical landscape. With a steadfast commitment to preventive healthcare, he employs a holistic approach to patient care that prioritizes clear communication and bilingual services to meet the diverse needs of his patients.

Currently, Dr. Fernandez Miro serves as the Medical Director and Principal Investigator at Global Health Clinical Trials and the Renova Aesthetics Institute, where he is at the forefront of innovative research and clinical trials. His work significantly advances medical knowledge, particularly in the realm of regenerative medicine, where he is a key figure in pioneering stem cell treatments at Miami Stem Cell.

Board Certification
  • Board Certified in Family Medicine
Current Roles
  • Medical Director & Principal Investigator — Global Health Clinical Trials
  • Medical Director — Renova Aesthetics Institute
  • Pioneering Stem Cell Researcher — Miami Stem Cell
Areas of Expertise
  • Preventive & holistic healthcare
  • Regenerative medicine & stem cell treatments
  • Clinical trials & medical research
  • Bilingual patient care (English & Spanish)

Get your consult

Aesthetics and Plastic Surgical Procedures Experience

Board-Certified Family Medicine Physician  ·  Miami

Dr. Humberto Fernandez Miro

Dr. Humberto Fernandez Miro is a highly esteemed board-certified physician with over 25 years of extensive experience in Miami's medical landscape. With a steadfast commitment to preventive healthcare, he employs a holistic approach to patient care that prioritizes clear communication and bilingual services to meet the diverse needs of his patients.

Currently, Dr. Fernandez Miro serves as the Medical Director and Principal Investigator at Global Health Clinical Trials and the Renova Aesthetics Institute, where he is at the forefront of innovative research and clinical trials. His work significantly advances medical knowledge, particularly in the realm of regenerative medicine, where he is a key figure in pioneering stem cell treatments at Miami Stem Cell.

Board Certification
  • Board Certified in Family Medicine
Current Roles
  • Medical Director & Principal Investigator — Global Health Clinical Trials
  • Medical Director — Renova Aesthetics Institute
  • Pioneering Stem Cell Researcher — Miami Stem Cell
Areas of Expertise
  • Preventive & holistic healthcare
  • Regenerative medicine & stem cell treatments
  • Clinical trials & medical research
  • Bilingual patient care (English & Spanish)

Research experience

Observational Registry of Treatment Patterns in U.S Heart Failure Patients with Reduce Ejection Fraction

Effect of Metformin HCL in Combination with Colesevelam HCL, Compared to Metformin HCL Alone as Initial Therapy in Drug Naïve Subjects with Type 2 Diabetes Mellitus

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) with Psoriasis Vulgaris.

Comprehensive Disease Management Program in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Community (COPD_CDM).

Effect of Colesevelam HCL on the lipid profile in Subject with Pre-Diabetes.

Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas

A study of Valsartan Administered once daily versus twice daily in patients with stable CHF.

Migraine Prevention using ActiPatch (PSWT)

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of SNA-120 Ointment in Subjects With Pruritus Associated With Psoriasis Vulgaris.

COPD Patients Diagnosed With GERD, COPD Exacerbations After Treatment with High Dose PPI

Airway Inflammation, Symptoms and Lung Function in COPD.

The effect of certolizumab on MRI Synovitis in Rheumatoid Arthritis.

A Phase III Protocol to evaluate Pharmacokinetic Comparison of Three NPH Insulin Preparations.

Impact Rituximab on MRI Evidence of Disease Activity in Patients with Rheumatoid Arthritis.

Comparative Randomized Bioavailability Study of a Combination Antihistamine and Decongestant Caplet given as a Single Dose.

A Randomized Multicenter, Double Blind, parallel Placebo Controlled Study of the effects of JNJ-28431754 on Cardiovascular Outcomes in Adults Subjects with type 2 Diabetes Mellitus (Johnson & Johnson Pharmaceutical research & development)

A multicenter, international, randomized parallel group, double blind study to evaluate Cardiovascular safety of linagliptin versus glimepiride in patients with type 2 Diabetes Mellitus at high cardiovascular risk. (Boehringer)

Cassiopeia, Facial Acne Study CB-03-01/25 A phase 3, Multicenter, randomized, double blind, vehicle controlled study to evaluate the safety and efficacy of Cortexolone 17 alpha propionate cream 1% applied twice daily for 12 weeks with subject with Facial Acne Vulgaris.

Skip to content
Explore
Drag